Studies of malabsorption occurring in patients with Laennec's cirrhosis.
D000328:Adult; D000368:Aged; D001706:Biopsy; D002446:Celiac Disease / Q000139:chemically induced / Q000209:etiology / Q000378:metabolism*; D004386:Duodenum / Q000382:microbiology; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007408:Intestinal Absorption; D007421:Intestine, Small / Q000378:metabolism* / Q000473:pathology; D007677:Kidney Function Tests; D050356:Lipid Metabolism; D008103:Liver Cirrhosis / Q000150:complications* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000009:adverse effects; D010182:Pancreatic Diseases / Q000150:complications; D010195:Pancreatitis / Q000150:complications*; D011446:Prospective Studies; D012189:Retrospective Studies; D012546:Schilling Test; D014994:Xylose
D007328:Insulin; D014994:Xylose; D009355:Neomycin